Cytochrome P-450 metabolites in renal circulation and excretion - Interaction with the nitric oxide (NO) system

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 9, 2008, Pages 137-149

  Kompanowska Jezierska, E ^a   Kuczeriszka, M ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

CYP 450 metabolites; Intrarenal circulation; NOS; Renal excretion; Sodium intake

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; HEME; HYPERTENSIVE FACTOR; NITRIC OXIDE; SODIUM; WATER; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; DIHOMO GAMMA LINOLENIC ACID; DRUG DERIVATIVE; HYDROXYICOSATETRAENOIC ACID; NITRIC OXIDE SYNTHASE;

BIOAVAILABILITY; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; DIURESIS; ELECTRODE; HIGH SODIUM INTAKE; INHIBITION KINETICS; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY FUNCTION; KIDNEY MEDULLA; LASER DOPPLER FLOWMETRY; METABOLITE; MOLECULAR INTERACTION; NONHUMAN; PROTECTION; SOLUTE; URINARY EXCRETION; WISTAR RAT; ANIMAL; BLOOD PRESSURE; DRUG ANTAGONISM; KIDNEY; MALE; METABOLISM; PHYSIOLOGY; RAT; REVIEW; SODIUM INTAKE; VASCULARIZATION; VASOCONSTRICTION;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ARACHIDONIC ACID; BLOOD PRESSURE; CYTOCHROME P-450 ENZYME SYSTEM; HYDROXYEICOSATETRAENOIC ACIDS; KIDNEY; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; SODIUM, DIETARY; VASOCONSTRICTION;

EID: 64049102900     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Imig JD. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors. Cardiovascular Drug Reviews 2006; 24(2): 169-188. (Pubitemid 46696923)
2. Zou AP, Fleming JT, et. al. Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K+-channel activity. Am J Physiol 1996; 270: F822-F832.
3. Spector AA, Norris AW. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 2007; 292: C996-C1012. (Pubitemid 46442641)
4. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82: 131-185. (Pubitemid 34654217)
5. Neuhofer W, Beck FX. Cell survival in the hostile environment of the renal medulla. Annu Rev Physiol 2005; 67: 531-555. (Pubitemid 40404500)
6. Pallone TL, Zhang Z, Rhinehart K. Physiology of renal medullary microcirculation. Am J Physiol Renal Physiol 2003; 284: F253-F266. (Pubitemid 36114688)
7. Herrera M, Garvin JL. Novel role of AQP-1 in NO-dependent vasorelaxation. Am J Physiol Renal Physiol 2007; 292: F1443-F1451. (Pubitemid 46701872)
8. Herrera M, Ortiz PA, Garvin JL. Regulation of thick ascending limb transport: role of nitric oxide. Am J Physiol Renal Fluid Electrolyte Physiol 2006; 290: F1279-F1284. (Pubitemid 43830750)
9. Majid DS, Navar LG. Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertension 2001; 14: 74S-82S.
10. Bouley R, Breton S, Sun TX, et. al. Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. J Clin Invest 2000; 106: 1115-1126.
11. Martin PY, Bianchi M, Roger F. Arginine vasopressin modulates expression of neuronal NOS in rat renal medulla. Am J Physiol Renal Physiol 2002; 283: 559-568.
12. Harder DR, Narayanan J, Birks EK, et. al. Identification of a putative microvascular oxygen sensor. Circ Res 1996; 79: 54-61.
13. Pallone TL, Silldorff EP Pericyte regulation of renal medullary blood flow. Exp Nephrol 2001; 9: 165-170. (Pubitemid 32429676)
14. Mattson DL. Importance of the renal medullary circulation in the control of sodium excretion and blood pressure. Am J Physiol Regul Integr Comp Physiol 2003; 284: R13-R27. (Pubitemid 36008650)
15. Zou AP, Li N, Cowley Jr. AW. Production and actions of superoxide in the renal medulla. Hypertension 2001; 37: 547-553. (Pubitemid 32199026)
16. Higashi Y, Oshima T, Ono N. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans. J Clin Endocr Metab 1995; 80: 239-242.
17. Wilcox CS. Role of macula densa NOS in tubuloglomerular feedback. Curr Opinion Nephrol Hypertens 1998; 7: 443-449. (Pubitemid 28341759)
18. Siragy HM, Inagami T, Carey RM. NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. Am J Physiol Regul Integr Comp Physiol 2007; 293: R1461-1467. (Pubitemid 47535763)
19. Imig JD. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal disease. Am J Physiol Renal Physiol 2005; 289: F496-F503. (Pubitemid 41208461)
20. Oyekan O. Differential effects of 20-hydroxyeicosatetraenoic acid on intrarenal blood flow on the rat. J Pharmacol Exp Ther 2005; 313(3): 1289-1295. (Pubitemid 40727034)
21. Wang J, Roman RJ, Falck JR. Effects of high-salt diet on CYP450-1A ω-hydroxylase expression and active tone in mesenteric resistance arteries. Am J Physiol Heart Circ Physiol 2005; 288: H1557-H1565. (Pubitemid 40417975)
22. Frisbee CJ, Falck JR, Lombard JH. Contribution of cytochrome P-450 ω-hydroxylase to altered arteriolar reactivity with high-salt diet hypertension. Am J Physiol Heart Circ Physiol 2000; 278: H1517-H1526. (Pubitemid 30395562)
23. Sarkis A, Roman RJ. Role of cytochrome P-450 metabolites of arachidonic acid in hypertension. Curr Drug Metab 2004; 5(3): 245-256. (Pubitemid 38735779)
24. Fleming I. Cytochrome P450 and vascular homeostasis. Circ Res 2001; 89: 753-762. (Pubitemid 34633845)
25. Hoagland KM, Flash AK, Roman RJ. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats. Hypertension 2003; 42: 669-673. (Pubitemid 37237307)
26. Kuczeriszka M, Badzynska B, Kompanowska-Jezierska E. Cytochrome P-450 monooxygenases in control of renal haemodynamics and arterial pressure in anaesthetized rats. J Physiol Pharmacol 2006; 57: 179-185. (Pubitemid 46569843)
27. Badzynska B, Grzelec-Mojzesowicz M, Sadowski J. Effect of exogenous angiotensin II on renal tissue nitric oxide and intrarenal circulation in anaesthetized rats. Acta Physiol Scand 2004; 182: 313-318. (Pubitemid 39468682)
28. Sarkis A, Lopez B, Roman J. Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension. Curr Opin Nephrol Hypertens 2004; 13: 205-213. (Pubitemid 38373143)
29. Ventura RR, Gomes DA, Reis WI, et. al. Nitrergic modulation of vasopressin, oxytocin and atrial natriuretic peptide secretion in response to sodium intake and hypertonic blood volume expansion. Braz J Med Biol Res 2002; 35: 1101-1109.
30. Dobrowolski L, Walkowska A, Kompanowska-Jezierska E, Kuczeriszka M, Sadowski J. Effects of ATP on rat renal haemodynamics and excretion: role of sodium intake, nitric oxide and cytochrome P450. Acta Physiol (Oxf) 2007; 189: 77-85. (Pubitemid 46092432)
31. Kuczeriszka M. The role of NO and CYT P-450 dependent active AA metabolites in rat kidney: dependence on sodium intake (in Polish). The doctoral thesis. M. Mossakowski Medical Research Center, Polish Academy of Sciences, Warsaw 2008.
32. Ortiz PA, Garvin JL. Role of nitric oxide in the regulation of nephron transport. Am J Physiol Renal Physiol 2002; 282: F777-F784. (Pubitemid 34654482)
33. Caron N, El Hajjam A, Decleves AE, Joly E, Falk JR, Kramp R. Changes in renal hemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases. Clin Exp Pharmacol Physiol 2004; 31: 683-690. (Pubitemid 39540317)
34. McGiff JC. Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol 1991; 31: 339-369. (Pubitemid 21903852)
35. Zou AP, Ma YH, Siu ZH, et. al. Effects of 17-Octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function in rats. J Pharmacol Exp Therap 1994; 268: 474-481.